Contact Us Contact Us IT Services IT Services Alumni Alumni

RAK MHSU Banner image
Dr. Javedh Shareef Profile Picture

Dr. Javedh Shareef

Associate Professor

Educational Qualification
  • PhD: Nitte University, Mangalore. Karnataka, India (2016). (Pharmaceutical Sciences)
  • M Pharm (Pharmacy Practice): Manipal Academy of Higher Education, Manipal, Karnataka, India (2005). (Pharmacy Practice)
  • B Pharm: The Tamil Nadu Dr MGR Medical University, Chennai, Tamil Nadu, India (2001)
Experience
  • Currently employed as Associate Professor, Dept. of Clinical Pharmacy & Pharmacology in RAK College of Pharmacy, Ras Al Khaimah Medical and Health Sciences University, UAE. (November 2024 - till date)
  • Worked as Assistant Professor, Dept. of Clinical Pharmacy & Pharmacology in RAK College of Pharmacy, Ras Al Khaimah Medical and Health Sciences University, UAE. (September 2018 - October 2024)
  • Worked as Assistant Professor in the Department of Pharmacy Practice in NGSM Institute of Pharmaceutical Sciences, Deralakatte, Mangalore, Karnataka, India from April 2012 to June 2017.
  • Worked as Adjunct Clinical Lecturer in College of pharmacy at the University of Sharjah, United Arab Emirates from September 2008 to March 2012.
  • Worked as a clinical pharmacist at Al Baraha Hospital, Deira, Dubai, UAE from 2006-2012.
Courses Taught

B Pharm

  • Introduction to Social Pharmacy 
  • Introduction to Pharmacy Practice
  • Pharmacy Practice – I & II  
  • Pharmacovigilance

Master of Science (Clinical Pharmacy)

  • Pharmacotherapeutics – II, III & IV
  • Advanced Clinical Pharmacy Practice
  • Hospital Pharmacy and Pharmacoinformatics
  • Clinical Pharmacokinetics

Publications
  • Srivastava S, Sah R, Babu MR, Sharma D, Sharma D, Kumar S, Sridhar SB, Wadhwa T, Shareef J, Rao GSNK, Feehan J, Apostolopoulos V, Sah S, Mehta R, Mehta V, Mohanty A, Zambrano L, Bonilla-Aldana DK, Luna C, Chaves TdS, Rodriguez-Morales AJ. The emergence of oropouche fever: A potential new threat? New Microbes New Infect. 2025 Jun; 65:101596. doi: 10.1016/j.nmni.2025.101596.
  • Prakash A, Sridhar SB, Wali AF, Talath S, Shareef J, Malviya R, Warsi MH. Polymeric brushes for enhanced biological applications: advancements in sustainable approach. Int J Polym Mater Polym Biomater. 2025;1–20. doi:10.1080/00914037.2025.2469167.
  • Rajput S, Malviya R, Prajapati BG, Sridhar SB, Shareef J. Nanoparticle troopers: Infiltrating cancer cells for targeted therapies. Nano-Structures & Nano-Objects. 2025; 41:101453. doi: 10.1016/j.nanoso.2025.101453.
  • Mai W, Sridhar SB, Karattuthodi MS, Ganesan PM, Shareef J, Lee EL, Armani K. Scoping review of enablers and challenges of implementing pharmacogenomics testing in the primary care settings. BMJ Open. 2024;14(11). https://doi.org/10.1136/bmjopen-2024-087064
  • Shareef J, Sridhar SB, Bhupathyraaj M, Shariff A, Thomas S. Exploring the community pharmacist’s knowledge, attitude, and practices regarding adverse drug reactions and its reporting in the United Arab Emirates: a survey-based cross-sectional study. Therapeutic Advances in Drug Safety. 2024;15. doi:10.1177/20420986241285930
  • Shareef J, Sridhar SB, Ismail ANA, Rao PGM, Ain Ur R. Assessment of potential drug-drug interactions in hospitalized patients with infectious diseases – an experience from a secondary care hospital. F1000Res. 2024; 13:164. doi:10.12688/f1000research.143186.1.
  • Shareef J, Sherin S, Sridhar SB, Abdulnazar S. General public knowledge, attitudes, and practice towards hair dye usage and its adverse effects in the northern Emirates of the United Arab Emirates. Turk J Pharm Sci. 2024; 21(6), pp. 506–512. doi: 10.4274/tjps.galenos.2024.33489.
  • Thomas S, Sridhar SB, Shareef J, et al. Ciclesonide inhaler for post-acute COVID-19 syndrome: Promising clinical evidence. Pharm Pract (Granada). 2024;22(3):2990. doi:10.18549/PharmPract.2024.3.2990. 
  • Shareef J, Sridhar SB, Bhupathyraaj M, Shariff A, Thomas S, Karattuthodi MS. Assessment of the scope, completeness, and consistency of various drug information resources related to COVID-19 medications in pregnancy and lactation. BMC Pregnancy Childbirth. 2023;23(1):296. doi: 10.1186/s12884-023-05609-2.
  • Nawa AIA, Shareef J, Rao PG, Rashid AU. Assessment of drug utilization pattern of antimicrobial agents in hospitalized patients with infectious diseases: a cross-sectional study in the United Arab Emirates. J Adv Pharm Technol Res. 2023;14(4):299–305. doi: 10.4103/japtr.japtr_79_23.
Achievements
  • Awarded special prize for the student oral presentation [Co-supervised MSCP Research] in the student scientific conference – 2025 for the presentation entitled ‘Assessment of Prescription Patterns and Drug-Related Problems Among Type 2 Diabetes Mellitus Patients Receiving Novel Anti-Diabetic Agents in the Outpatient Department of a Secondary Care Hospital in the United Arab Emirates.’
  • Awarded 1st prize for the student oral presentation [Co-supervised graduate Research] in the student scientific conference – 2025 for the presentation entitled ‘A Comparative Analysis of Drug Information Quality Between Artificial Intelligence and Standard Databases.’
  • Awarded best student oral presentation [Co-supervised MSCP Research] in the student scientific conference – 2023 for the poster entitled ‘Pill Pairs: Evaluating the Potential Drug Interactions with Non-Steroidal Anti-Inflammatory Drugs in a Secondary Care Hospital’
  • Presented “Research excellence award’ for the presentation on “Assessment of the Scope, Completeness, and Consistency of Various Drug Information Resources Related to Covid-19 Medications in Pregnancy and Lactation” at the “7th World Congress on Womens Health and Midwifery” held during December 09, 2022 | Webinar
  • Awarded Best Oral Presentation for the topic Potential Psychotropic and COVID-19 Drug Interactions: A Comparison of Integrated Evidence from Six Database Programs”